Novel blood biomarkers such as plasma phosphorylated tau isoforms (pTau181, 217, and 231) will be of great importance, taking into account the cost, the convenience, and the high diagnostic accuracy already proven in AD [54,55]. The gene discussed is MAPT; the disease is Alzheimer disease.